The administration of MSC secretome gave an immunoregulatory effect in the form of a decreased expression of NF-κB p65 and p50, as well as a decrease in the serum TNF-α level, and an increased serum IL-10 level in rat model of sepsis. This evidence concerns the gene IL10 and Sepsis.